Literature DB >> 32750389

Current Knowledge and Future Directions in Developing Strategies to Combat Pseudomonas aeruginosa Infection.

Stephen K Dolan1.   

Abstract

In the face of growing antimicrobial resistance, there is an urgent need for the development of effective strategies to target Pseudomonas aeruginosa. This metabolically versatile bacterium can cause a wide range of severe opportunistic infections in patients with serious underlying medical conditions, such as those with burns, surgical wounds or people with cystic fibrosis. Many of the key adaptations that arise in this organism during infection are centered on core metabolism and virulence factor synthesis. Interfering with these processes may provide a new strategy to combat infection which could be combined with conventional antibiotics. This review will provide an overview of the most recent work that has advanced our understanding of P. aeruginosa infection. Strategies that exploit this recent knowledge to combat infection will be highlighted alongside potential alternative therapeutic options and their limitations. Crown
Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pseudomonas; bacteria; infection; metabolism; virulence

Mesh:

Substances:

Year:  2020        PMID: 32750389     DOI: 10.1016/j.jmb.2020.07.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development.

Authors:  Francois Lebreton; Erik Snesrud; Lindsey Hall; Emma Mills; Madeline Galac; Jason Stam; Ana Ong; Rosslyn Maybank; Yoon I Kwak; Sheila Johnson; Michael Julius; Melissa Ly; Brett Swierczewski; Paige E Waterman; Mary Hinkle; Anthony Jones; Emil Lesho; Jason W Bennett; Patrick McGann
Journal:  JAC Antimicrob Resist       Date:  2021-12-10

2.  Enhanced Biosynthesis of Fatty Acids Contributes to Ciprofloxacin Resistance in Pseudomonas aeruginosa.

Authors:  Yu-Bin Su; Xi-Kang Tang; Ling-Ping Zhu; Ke-Xin Yang; Li Pan; Hui Li; Zhuang-Gui Chen
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

3.  Repressed Central Carbon Metabolism and Its Effect on Related Metabolic Pathways in Cefoperazone/Sulbactam-Resistant Pseudomonas aeruginosa.

Authors:  Yue-Tao Chen; Ke-Xin Yang; Zhen-Yuan Dai; Huan Yi; Xuan-Xian Peng; Hui Li; Zhuang-Gui Chen
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

4.  Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa.

Authors:  Xi-Kang Tang; Yu-Bin Su; Hui-Qing Ye; Zhen-Yuan Dai; Huan Yi; Ke-Xin Yang; Tian-Tuo Zhang; Zhuang-Gui Chen
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

Review 5.  The therapeutic potential of Houttuynia cordata: A current review.

Authors:  C Laldinsangi
Journal:  Heliyon       Date:  2022-08-24

6.  Draft Genome Sequence of the Multiple Antibiotic Resistant Pseudomonas aeruginosa PAO1-UB Subline.

Authors:  Kah-Ooi Chua; Paul Norton; Pavlos Trus; Maria Katsikogianni; M Julie Thornton; Kok-Gan Chan; Chien-Yi Chang
Journal:  Microbiol Resour Announc       Date:  2022-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.